Venture Capital

Updated:

Eshelman Ventures

Eshelman Ventures, LLC is an investment company primarily interested in private healthcare companies. Fred Eshelman is the founder and often serves on the...

Eshelman Ventures logo

Eshelman Ventures

Eshelman Ventures, LLC is an investment company primarily interested in private healthcare companies. Fred Eshelman is the founder and often serves on the boards of portfolio companies. Its investment approach is one of active involvement in growth and strategy.

General information

Firm type

Venture Capital

Year founded

2014

Location

Region

North America

Country

United States

City

Wilmington

Corporate office

5815 Oleander Drive Ste 105, Wilmington, NC 28403, United States

Principals

Fred Eshelman

Founder

Nan Howard

Contact

Ashley Miller

Contact

Sector focus

Healthcare ServicesPharmaceuticals

Frequently asked questions

Does Eshelman Ventures participate in fund commitments or only direct deals?

The firm states it invests through multiple channels: angel investing in startups, co-investing alongside venture capital funds, committing to private equity funds on the primary and secondary markets, backing academic spinouts, and allocating to hedge funds. It does not publish the ratio of direct to fund commitments.

Which sectors does Eshelman Ventures explicitly avoid?

The firm’s stated focus is healthcare companies, and its disclosed portfolio is almost exclusively biotechnology and pharmaceuticals. There is no indication that it invests in sectors such as consumer technology, financial services, or industrial technology, with the exception of one 3D printing company, Carbon.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Wilmington Venture Capital profiles